— DexCom, Inc. (NASDAQ: DXCM) reported its fourth-quarter 2019 adjusted earnings of $1.15 per share versus $0.74 per share expected.
— Total revenue grew by 37% to $462.8 million versus $442.38 million expected. This is driven by volume growth, strong new patient additions as well as an increase in awareness of real-time CGM.
— The US revenue increased by 34% year-over-year and the international revenue jumped by 52%.
— Revenue from the sensor increased by 42% for the fourth quarter. Transmitter revenue jumped by 46% while receiver revenue plunged by 35%.
— Looking ahead into the full year 2020, the company reaffirmed revenue outlook in the range of $1.725-1.775 billion. This is in line with the consensus view of $1.77 billion.
— The revenue outlook is driven by strong growth in sensor volumes, continued international expansion, shifting channel mix and overall market dynamics.
— The gross margin is still expected to be about 64% and the adjusted operating margin is predicted to be about 13%. The adjusted EBITDA margin outlook is about 23%.
Adobe, Inc. (NASDAQ: ADBE) has been dominating the design software space for quite some time, all along staying resilient to macroeconomic fluctuations and market headwinds. The company’s cloud-based applications, offered
Brilliant Earth IPO: Here are a few points to note about this jewelry company that goes public next week
Jewelry has always played a significant role in people’s lives. As life begins to go back to normal after the pandemic and people start attending social events, they are looking
Tell us about BioCloud, how it’s different from any alternate existing products, and your distribution model. BioCloud exists as a part of Kontrol Technologies and is an innovation within our